HIV News and Research

RSS

How obesity, diet and exercise influence our metabolism and interact with our genome

Research by kinesiology investigator Dustin Hittel, PhD, has proven that muscle in extremely obese individuals produces large amounts of a protein called myostatin, which normally inhibits muscle growth-suggesting that for Type 2 diabetics, and the very obese, the task of getting healthy may be more difficult than initially thought.

26 Feb 2009

Drug combo shows potential for treating extensively drug resistant tuberculosis

A combination of two FDA-approved drugs, already approved for fighting other bacterial infections, shows potential for treating extensively drug resistant tuberculosis (XDR-TB), the most deadly form of the infection.

26 Feb 2009

Mylan's Matrix receives WHO approval for generic Lopinavir/Ritonavir tablets

Mylan Inc. has announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.5% controlling interest, received the first and only World Health Organization (WHO) approval for Lopinavir/Ritonavir Tablets, 200 mg/50 mg. Matrix's version of this product is heat-stable and affordable, making it practical for distribution and use in warm climates.

25 Feb 2009

Implicit licenses clinical stage antibody program from Lilly

Implicit Bioscience Ltd has announced the acquisition of the clinical-stage monoclonal antibody IC14 from Eli Lilly and Company. Implicit has paid an undisclosed consideration combining cash and stock to Lilly. Lilly will also receive a royalty on future IC14 sales.

25 Feb 2009

Study finds major interruptions in antiretroviral therapy after release from prison

The vast majority of HIV-infected Texas prison inmates who receive antiretroviral therapy while incarcerated experience significant interruptions in HIV treatment after their release into the community.

24 Feb 2009

Inexpensive depression screening tool works in resource poor countries

A study published in the February 2009 issue of the Journal of General Internal Medicine reports that a highly reliable depression screening tool known as the Patient Health Questionnaire-9 (PHQ-9) used across the United States and Europe can be effectively administered in resource poor Africa to HIV/AID patients, a population whose mental health needs have been underserved.

24 Feb 2009

AIDS Healthcare Foundation launches "Stay Negative" HIV testing campaign

AIDS Healthcare Foundation (AHF) , which operates the largest community-based alternative HIV and sexually transmitted disease (STD) testing program in California, has launched an innovative and eye-catching Los Angeles-area HIV prevention and testing campaign urging the public to "Stay Negative" and to visit www.freehivtest.net to find out where to get tested quickly, conveniently and at no cost.

23 Feb 2009

Basis of immunity to oral thrush, common in AIDS, identified by UB researchers

Oral thrush, a hallmark symptom in AIDS patients, is caused by a type of yeast that grows unchecked in people with weakened immune systems, and appears in colonies of white patches in the mouth.

23 Feb 2009

Global AIDS Alliance sounds alarm on potential budget cuts

Amid initial indications that the administration's first budget will flat-line funding for global health, the Global AIDS Alliance is calling on President Obama, Vice President Biden and Secretary of State Hillary Clinton to keep their campaign commitments to scale up the President's Emergency Plan for AIDS Relief (PEPFAR) and accelerate efforts to ensure every child around the world gets a free basic education.

23 Feb 2009

Gene therapy shows potential against HIV

A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV.

22 Feb 2009

New study debunks misconceptions about barriers to the CDC's HIV testing recommendations

Since the Centers for Disease Control and Prevention (CDC) released revised recommendations for opt-out HIV testing in 2006, there has been significant debate around the barriers to widespread implementation of the recommendations.

17 Feb 2009

Radioimmunotherapy shows promise for HIV infection and viral cancers

Scientists at Albert Einstein College of Medicine of Yeshiva University have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells.

16 Feb 2009

ViroPharma reports results of trial for Maribavir in bone marrow transplant patients

ViroPharma Incorporated has announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint.

10 Feb 2009

Adolescents should participate in decisions about end-of-life care

Conversations between adolescents suffering from chronic illnesses and their families about end-of-life wishes well before a serious event occurs won't discourage hope for recovery or cause additional emotional or mental harm to young patients, according to new research from Children's National Medical Center and St. Jude Children's Research Hospital published in the journal Pediatrics.

9 Feb 2009

Anti-HIV vaginal gel shows promise

An investigational vaginal gel intended to prevent HIV infection in women has demonstrated encouraging signs of success in a clinical trial conducted in Africa and the United States.

9 Feb 2009

World experts meet in Australia to find ways to wipe out malaria

Australia is host to a meeting of World health experts which aims to find ways of eradicating malaria, one of the world's most dangerous killer diseases.

9 Feb 2009

Scientists create first crystal structure of an intermediate particle in virus assembly

The structure, described February 8 in an advance online publication of the journal Nature , provides fresh insights into the elegant dance that viral proteins perform to create the infectious structure that causes all manner of misery and disease, say researchers.

8 Feb 2009

Idenix Pharmaceuticals and GSK sign agreement for novel NNRTI for treatment of HIV

Idenix Pharmaceuticals, Inc. and GlaxoSmithKline (GSK) today announced the execution of a license agreement granting GSK exclusive worldwide rights to IDX899.

8 Feb 2009

Sangamo BioSciences starts trial of CCR5-ZFP therapeutic to treat HIV/AIDS

Sangamo BioSciences, Inc. has announced that its collaborators at the University of Pennsylvania have opened a Phase 1 clinical trial to evaluate SB-728-T for the treatment of HIV/AIDS.

5 Feb 2009

Many neglected diseases lacking research funding

The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine , finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total

5 Feb 2009